ASTA Comments to FDA on Voluntary Sesame Labeling Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
Multi-Industry Industry Letter to Congressional Appropriators in Support of Foodborne Diseases Active Surveillance Network (FoodNet)
ASTA signed onto a multi-industry letter to Congressional leaders on the Appropriations Subcommittee on Labor, Health, and Human Services, Education, and related agencies to support the Foodborne Diseases Active Surveillance Network (FoodNet), the only active foodborne illness surveillance network in the United States. FoodNet has established a proven track record of detecting foodborne illness cases and generating the most reliable, population-based estimates of disease prevalence.
Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
